Evaluation of target organs damage in hypertensive patients - PreVENT-A GP
Study identifier:NIS-CFR-DUM-2009/2
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
Evaluation of target organs damage in hypertensive patients followed in general practice with no known cardiovascular (CV) or renal disease, stratified according to blood pressure control
Medical condition
target organs damage
Phase
-
Healthy volunteers
No
Study drug
-
Sex
All
Actual Enrollment
1857
Study type
Observational
Age
18 Years +
Date
Study Start Date: 01 Jan 2010
Primary Completion Date: 01 Jun 2010
Study Completion Date: 01 Jun 2010
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Dec 2014 by AstraZeneca Pharmaceuticals
Sponsors
AstraZeneca Pharmaceuticals
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
Contacts
Investigators
Principal Investigator
Pascal Piedbois
AstraZeneca
